Navigation Links
FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S.
Date:4/17/2008

Agency Approves Expansion of Company's Phase 3 Study for Wet AMD after

90-day Review of Safety Data

FREMONT, Calif., April 17 /PRNewswire/ -- NeoVista, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company's request to expand the number of sites participating in its pivotal Phase 3 trial from 10 to 30 in the United States. The approved expansion of CABERNET (CNV Secondary to AMD Treated with BEta RadiatioN Epiretinal Therapy) trial, which seeks to evaluate the safety and efficacy of the company's novel epiretinal brachytherapy for the wet form of age-related macular degeneration (AMD), was dependent on the FDA's review of 90-day safety data, typical of new-to-market medical devices.

"With this expansion to 30 sites, we will not only be able to recruit more patients at a higher rate, taking us one step closer to commercialization in the United States, but it will also allow additional retina specialists to see the benefits of our novel therapy first-hand while treating their patients," said John N. Hendrick, President and CEO of NeoVista. "It's an exciting time at NeoVista with our recent CE Mark approval in the EU and the FDA approval of our trial expansion. We are getting closer and closer to seeing our investigational therapy become an approved treatment option for millions of patients worldwide afflicted with wet AMD."

CABERNET is a multicenter, randomized, controlled study that will enroll 450 subjects at clinical centers worldwide. The study will evaluate the safety and efficacy of NeoVista's epiretinal brachytherapy, delivered utilizing a limited vitrectomy, concomitant with two intravitreal injections of the FDA-approved antiangiogenic therapy Lucentis(R) (ranibizumab) versus Lucentis alone. For those enrolled in the trial arm utilizing brachytherapy, Lucentis is injected once at the time of the surgery and once again 30 days later. The co-primary endpoints in the CAB
'/>"/>

SOURCE NeoVista, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
2. Chinese SFDA Grants Immtech Fast Track Status
3. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
4. NTMir Announces Research Grants for Epidemiology and Household Water as Source of Infection
5. FDA Grants Approval to Extend U.S. Enrollment and Clinical Trial
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. FDA Grants Priority Review for ACIPHEX(R) (rabeprazole sodium) sNDA for Short-Term Treatment of GERD in Adolescents
8. FDA Grants Priority Review for PROMACTA(R) (eltrombopag)
9. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
10. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
11. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 A study led by St. ... chemotherapy dose threshold below which male childhood cancer survivors ... appears in September 17 edition of the journal ... are at highest risk for reduced sperm production as ... of pre-treatment fertility preservation methods such as sperm banking. ...
(Date:9/16/2014)... CHICAGO , Sept. 16, 2014 The ... submitted survey data from more than 1,100 patients and ... Food and Drug Administration (FDA) for the Patient-Focused Drug ... This is a new FDA initiative to seek patient ... expectations for therapeutic treatments. "We applaud the ...
(Date:9/16/2014)... 2014 Astellas announced today it has ... & Advocacy, Urology in the Americas. Noland will report ... Margaret Long. In this role, Noland will be responsible ... and advocacy organizations, as well as collaborating with ... Noland,s appointment is the latest phase in the ...
Breaking Medicine Technology:Improved risk identification will aid fertility preservation in young male cancer patients 2Improved risk identification will aid fertility preservation in young male cancer patients 3Improved risk identification will aid fertility preservation in young male cancer patients 4PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 2PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 3PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 4Christy Noland to Lead Urology Advocacy and Communications for Astellas 2
(Date:9/17/2014)... 17, 2014 U.S. News and ... the country, and three mesothelioma treatment centers made ... the mesothelioma law firm Baron and Budd ... University of Texas MD Anderson Cancer Center and ... publication. ( http://health.usnews.com/best-hospitals/rankings/cancer ) , U.S. News and ...
(Date:9/17/2014)... DMG Productions announces the upcoming ... to broadcast on Wednesday, September 24, 2014 at ... this episode, Innovations will go behind the scenes ... provide each client the opportunity to achieve the ... the principles of Care, Compassion, and Commitment. , ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Experienced dress ... making a new selection of trendy black bridesmaid dresses. ... for all its beautiful bridesmaid outfits. Readers can ... , Discount-Dress.com is a famous brand ... of new additions as well as revamped old editions, ...
(Date:9/17/2014)... Headquartered in Baltimore, Maryland, Therapy ... the country. , “The past two weeks have ... grown to over 400 evaluators in 46 states, and ... the Midwest and South Dakota and Vermont. And from ... our volunteers can visit.” , TPU provides one-of-a-kind treatment ...
(Date:9/17/2014)... Request A Test , a leading national provider of ... drug testing through the end of September 2014. ... by employers for workplace or new hire screenings. Employers ... promo code DRUG10 when placing an order. Statistics have ... especially for marijuana or THC. Request A Test offers ...
Breaking Medicine News(10 mins):Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 2Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 3Health News:Innovations to Explore Substance Abuse and Mental Health in Upcoming Episode Airing Wednesday, September 24, 2014 via Discovery Channel. 2Health News:Discount-Dress.com’s Top Designers Are Now Busy Making Its New Black Bridesmaid Dresses 2Health News:Therapy Pets Unlimited is Expanding 2Health News:Therapy Pets Unlimited is Expanding 3Health News:Request A Test Can Save You 10% on Drug Testing 2Health News:Request A Test Can Save You 10% on Drug Testing 3
... Heart patients and cardiologists across the country are ... access be preserved as discussions about healthcare ... for Medicare and Medicaid Services (CMS) - scheduled to ... the accessibility of life-saving cardiology testing and services currently ...
... Health System study has found that high-risk surgery ... were seen by general internists trained in managing ... underwent high-risk orthopaedic surgeries experienced shorter stays when ... surgeons. And, the study found, patients reported they ...
... true for current H1N1 strain remains a mystery, , THURSDAY, ... 1918 Spanish flu pandemic while still in their mother,s womb ... 60 years later, a new study has found. , The ... people worldwide, including 500,000 in the United States. That flu, ...
... Effort Illustrates Broad Public Support for Addressing Crisis ... Oct. 1 Citizens of Delaware ... and wellness with the launch today of "Say ,Yes, to ... video campaign of the Partnership to Fight Chronic Disease (PFCD) ...
... Pink Sheets Filings Reply To Shareholders ... General Corporate Update, , SHENZHEN, China, Oct. 1 /PRNewswire-FirstCall/ ... based operating subsidiary Mellow Hope and Serbia operating Subsidiary ... attention to today,s Pink Sheets filing. The filing found ...
... Whether they can have children is one of the ... cancer because fertility can be compromised by cancer treatment. ... studies led by researchers at Fred Hutchinson Cancer Research ... will adversely impact their newborns. The studies, presented as ...
Cached Medicine News:Health News:Proposed Medicare Changes Will Increase Costs to Government, Decrease Options for Patients 2Health News:Proposed Medicare Changes Will Increase Costs to Government, Decrease Options for Patients 3Health News:How to reduce hospital stays and increase patient satisfaction 2Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 2Health News:Pre-Birth Exposure to 1918 Flu Raised Heart Risks, Study Finds 3Health News:Delaware Residents Participate in Launch of National Video Campaign: 'Say 'Yes' to Health Reform' 2Health News:Delaware Residents Participate in Launch of National Video Campaign: 'Say 'Yes' to Health Reform' 3Health News:Hard to Treat Diseases (HTDS) Management Discussion 2Health News:Hard to Treat Diseases (HTDS) Management Discussion 3Health News:Studies find few risks to newborn offspring of parents who are childhood cancer survivors 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: